First Time Loading...

Rhinomed Ltd
ASX:RNO

Watchlist Manager
Rhinomed Ltd Logo
Rhinomed Ltd
ASX:RNO
Watchlist
Price: 0.04 AUD Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

RNO Price Targets Summary
Rhinomed Ltd

There are no price targets for RNO.
RNO Lowest Forecast
Wall Street Target
Not Available
RNO Average Forecast
Wall Street Target
Not Available
RNO Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Rhinomed Ltd Competitors:
Price Targets
G
002275
Guilin Sanjin Pharmaceutical Co Ltd
12% Upside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
W
WOCKPHARMA
Wockhardt Ltd
22% Downside
4151
Kyowa Kirin Co Ltd
19% Upside
G
002275
Guilin Sanjin Pharmaceutical Co Ltd
12% Upside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
W
WOCKPHARMA
Wockhardt Ltd
22% Downside
4151
Kyowa Kirin Co Ltd
19% Upside
234080
JW Life Science Corp
47% Upside
G
512
Grand Pharmaceutical Group Ltd
78% Upside
NEU
Neuren Pharmaceuticals Ltd
42% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
18% Downside

Revenue
Forecast

Revenue Estimate
Rhinomed Ltd

For the last 8 years the compound annual growth rate for Rhinomed Ltd's revenue is 41%. The projected CAGR for the next 7 years is -14%.

41%
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rhinomed Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rhinomed Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
RNO intrinsic value, competitors valuation, and company profile.
DCF Valuation
RNO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RNO stock valuation using valuation multiples.
Wall Street Estimates
RNO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RNO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNO's stock price target?
Not Available

RNO doesn't have any price targets made by Wall Street professionals.

What is Rhinomed Ltd's Revenue forecast?
Projected CAGR
-14%

For the last 8 years the compound annual growth rate for Rhinomed Ltd's revenue is 41%. The projected CAGR for the next 7 years is -14%.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.